Found 0 matching trials
Neoadjuvant Immunotherapy in Brain Metastases PHASE2 The purpose of this phase 2 study is to assess the feasibility and efficacy...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD) PHASE2 This is a multi-center, randomized, controlled open-label add-on design tri...
Show More Location
UCSF Benioff Children's Hospital
Learn More & Join Trial
A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy PHASE2 Head and neck cancer is the malignant tumor with the highest morbidity and ...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced but Resecable Colon Cancer in the Elderly of 70 Years Old or More PHASE3 Colon cancer (CC) is the 5th most common cancer worldwide. Standard care fo...
Show More Location
CHU Dijon Bourgogne
Learn More & Join Trial
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study. PHASE2 This is a multicenter, two-arm, exploratory clinical study designed to eval...
Show More Location
The Fourth Hospital of Hebei Medical University
Learn More & Join Trial
Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer EARLY_PHASE1 This early phase I trial studies giving propranolol hydrochloride with stan...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients PHASE3 Breast cancer is the most common malignant tumor in women. Recurrent or met...
Show More Learn More & Join Trial
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery PHASE2 This phase II trial studies how well chemotherapy before surgery and radiat...
Show More Status
Active Not Recruiting
Location
University of Arizona Cancer Center-Orange Grove Campus
Learn More & Join Trial
Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung Cancer PHASE2 Src expression has been identified in a majority of Non-Small Cell Lung Can...
Show More Location
Duke University Medical Center
Learn More & Join Trial